Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1011 to 1020 of 2521

TitleReference numberPublishedLast updated
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)TA634
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)TA635
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)TA636
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedureTA626
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasiaHTG545
MolecuLight i:X for wound imagingMIB212
Actim Pancreatitis for diagnosing acute pancreatitisMIB218

Results per page

  1. 10
  2. 25
  3. 50
  4. All